Archive - June 2023

New Drugs

CMP Pharma, Inc Announces that Liqrev, the First and Only Ready-made FDA-approved Liquid Suspension of Sildenafil is Now Available

2 years ago

Healthcare News • Pharma Industry News

Pfizer's TALZENNA® in combination with XTANDI® receives U.S. FDA approval

2 years ago

New Drugs

FDA Approves Lodoco (colchicine) as the First Anti-Inflammatory Drug for Cardiovascular Disease

2 years ago

New Drugs

FDA Approves Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) for Subcutaneous Use in Generalized Myasthenia Gravis

2 years ago

New Drugs

Pfizer’s Talzenna (talazoparib) in Combination with Xtandi (enzalutamide) Receives U.S. FDA Approval for HRR Gene-Mutated Metastatic Castration-Resistant Prostate Cancer

2 years ago

New Drugs

FDA Approves New Class of Medicines to Treat Pediatric Type 2 Diabetes

2 years ago

Pharma Industry News

The patient, AI and the search for answers

2 years ago